LGP
Director Trades
| Date | Director | Value |
|---|
Company News
Trump’s CBD Comments Ignite US Cannabis Stocks Surge – Will ASX Companies Follow Suit?
Shares of cannabis and CBD-related companies surged on Monday after US President Donald Trump posted on Truth Social that hemp-derived cannabidiol (CBD), especially in senior healthcare, “could revolutionize” treatment by reducing disease progression and providing an alternative to prescription drugs. He further reiterated his administration is exploring reclassifying marijuana under federal law, a change that could […]
Little Green Pharma takes delivery of first cannabis flower shipment from new Danish growing facility
Perth-based medicinal cannabis producer Little Green Pharma (ASX: LGP) has taken delivery of the first shipment of cannabis flower medicines from its new growing facility in Denmark. The company imported approximately 50 kilograms of “Billy Buttons” THC (tetrahydrocannabinol) flower, approximately two months after finalising the $21.4 million acquisition. Named after an Australian wildflower, the medicine […]
Little Green Pharma grows full-year profits to record $24.6m
Australian medicinal cannabis producer Little Green Pharma (ASX: LGP) has recorded a healthy FY 2021 performance, generating over $7 million in revenue to 30 June and banking a record profit after tax of $24.6 million. The company’s revenue from ordinary activities exceeded the previous year’s loss of $9.3 million and included gains on the $24.9 […]
Little Green Pharma posts ‘transformational quarter’ of acquisition and distribution deals
The three months to 30 June signified a “transformational quarter” for Australian medicinal cannabis producer Little Green Pharma (ASX: LGP). The $21.4 million acquisition of a world-class GMP (good manufacturing practice) facility in Denmark and the completion of a $27.2 million placement with support from private mining company Hancock Prospecting provided a strategic platform to […]
Little Green Pharma accelerates medicinal cannabis growth plans with purchase of Danish manufacturing facility
Perth-based medicinal cannabis producer Little Green Pharma (ASX: LGP) has accelerated its global growth plans with the $21.48 million acquisition of a cultivation facility in Denmark owned by Canada’s Canopy Growth Corporation. Comprising a 21,500 square metre cultivation site and 4,000sq m post-harvest GMP (good manufacturing practice) site, the facility meets European Union GACP (good […]
Little Green Pharma secures deal to distribute medicinal cannabis products in Poland
Perth-based medicinal cannabis producer Little Green Pharma (ASX: LGP) has secured a five-year agreement with Polish company Medezin Sp. z.o.o for the distribution of its homegrown medicinal cannabis oils and flower products. Medezin is owned by Pelion SA, which is the largest operator in the Polish and Lithuanian healthcare sector with 30 years’ experience and […]
Growing market share is priority work for local medicinal cannabis producer Little Green Pharma
Sixteen months after making its ASX debut, vertically integrated exporter of locally-grown cannabis products Little Green Pharma (ASX: LGP) is proving there is really nothing “little” about its business at all. Founded in 2016 to improve a young patient’s quality of life, the then privately-owned company started its journey with one of the first few […]
Drawbacks of the TGA’s cannabis changes for listed pot stocks
Having been subject to a harsh reality check over the last year or so, the ASX-listed cannabis sector is applauding the local medicine regulator’s endorsement of the weed as an effective therapy that should be more freely available to the ailing masses. But the path to the pharmacy is likely to be harder than they […]
Little Green Pharma eyes ASX listing to grow medical cannabis exports
Australian medical cannabis grower Little Green Pharma plans to make its ASX debut next month, hoping to boost efforts to distribute its locally-grown products in international markets. According to its prospectus lodged before Christmas, the company aimed to raise $10 million through the offer of 22.22 million shares at an issue price of $0.45 each. […]
Little Green Pharma obtains expanded medicinal cannabis licence
Medical cannabis grower Little Green Pharma (ASX: LGP) has been given a significant operational boost in the form of an expanded medicinal cannabis licence and a new manufacturing licence from Australia’s Office of Drug Control (ODC). Obtaining a manufacturing licence covers Little Green’s new manufacturing facility at which it intends to produce cannabis extracts for development […]
